Frankfurt - Delayed Quote EUR

NovoCure Limited (038.F)

14.69

+0.62

+(4.44%)

At close: April 10 at 8:25:20 AM GMT+2

Revenue vs. Earnings

Revenue 161.27M

Earnings -65.92M

Q1'24

Q2'24

Q3'24

Q4'24

-50M

0

50M

100M

150M

Analyst Price Targets

No Analyst Price Targets available for this ticker

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
No. of Analysts	--	--	--	--
Avg. Estimate	0	0	0	0
Low Estimate	0	0	0	0
High Estimate	0	0	0	0
Year Ago EPS	--	--	--	--

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
No. of Analysts	7	7	7	7
Avg. Estimate	147.49M	150.45M	613.62M	677.09M
Low Estimate	145M	148M	608M	649M
High Estimate	150.3M	152.1M	619M	701.7M
Year Ago Sales	138.5M	150.36M	605.22M	613.62M
Sales Growth (year/est)	6.49%	0.06%	1.39%	10.34%

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
Current Estimate	0	0	0	0
7 Days Ago	0	0	0	0
30 Days Ago	0	0	0	0
60 Days Ago	0	0	0	0
90 Days Ago	0	0	0	0

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
Up Last 7 Days	--	--	--	--
Up Last 30 Days	--	--	--	--
Down Last 7 Days	--	--	--	--
Down Last 30 Days	--	--	--	--

	Current Qtr.	Next Qtr.	Current Year	Next Year
038.F	--	--	--	--
S&P 500	6.43%	6.13%	9.43%	14.26%

Maintains	JP Morgan: Neutral to Neutral	4/10/2025
Reiterates	HC Wainwright & Co.: Buy to Buy	1/14/2025
Maintains	Piper Sandler: Overweight to Overweight	12/13/2024
Maintains	HC Wainwright & Co.: Buy to Buy	12/3/2024
Reiterates	HC Wainwright & Co.: Buy to Buy	12/2/2024
Upgrade	Evercore ISI Group: In-Line to Outperform	12/2/2024